Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Opthea (OPT) Profit Margin (2004 - 2025)

Opthea (OPT) profit margin from Jun 30, 2004 to Mar 31, 2025. The current Opthea (OPT) profit margin is -24800.00%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Opthea (OPT)

YearProfit MarginChange
2024-183533.33%
+38.59%
2023-132425.00%
+34.50%
2022-98453.85%
+45.76%
2021-67544.44%
+528.52%
2020-10746.67%
-43.47%
2019-19009.09%
+72.81%
2008-11000.00%
-123.16%
200747500.00%
-71.39%
2005166000.00%
N/A

Comparison Opthea (OPT) profit margin with competitors

Opthea (OPT) profit margin is -24800.00%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%-103.51%
PRTCPureTech Health plc American Depositary Shares793.00%-103.20%
ABEOAbeona Therapeutics Inc454.90%-101.83%
CHRSCoherus Biosciences Inc397.30%-101.60%
FBIOFortress Biotech Inc193.10%-100.78%
INVAInnoviva Inc119.90%-100.48%
ZVRAZevra Therapeutics Inc101.60%-100.41%
ABUSArbutus Biopharma Corp94.73%-100.38%
SAVACassava Sciences Inc.93.68%-100.38%
GLPGGalapagos NV86.83%-100.35%
CTNMContineum Therapeutics Inc - Class A83.13%-100.34%
BDTXBlack Diamond Therapeutics Inc80.77%-100.33%
NEUPNeuphoria Therapeutics Inc75.08%-100.30%
IPSCCentury Therapeutics Inc70.13%-100.28%
FULCFulcrum Therapeutics Inc69.26%-100.28%
CVACCureVac N.V.68.44%-100.28%
PRTAProthena Corporation plc64.05%-100.26%
QTTBQ32 Bio Inc61.90%-100.25%
AVIRAtea Pharmaceuticals Inc60.95%-100.25%
ASNDAscendis Pharma A/S57.30%-100.23%
PLXProtalix BioTherapeutics Inc54.27%-100.22%
HCWBHCW Biologics Inc53.42%-100.22%
AGENAgenus Inc52.20%-100.21%
CGENCompugen Ltd48.57%-100.20%
KRYSKrystal Biotech Inc48.07%-100.19%
RPRXRoyalty Pharma plc - Class A46.73%-100.19%
XOMAPXOMA Royalty Corp45.90%-100.19%
XOMAOXOMA Royalty Corp45.90%-100.19%
AUPHAurinia Pharmaceuticals Inc44.21%-100.18%
NXTCNextcure Inc43.49%-100.18%
CPRXCatalyst Pharmaceuticals Inc42.66%-100.17%
HALOHalozyme Therapeutics Inc39.83%-100.16%
ADMAAdma Biologics Inc39.59%-100.16%
XOMAXOMA Royalty Corp36.25%-100.15%
VRTXVertex Pharmaceuticals Inc34.53%-100.14%
EXELExelixis Inc34.46%-100.14%
SLNOSoleno Therapeutics Inc33.17%-100.13%
CRMDCorMedix Inc30.29%-100.12%
TNGXTango Therapeutics Inc29.52%-100.12%
ARGXArgen X SE28.20%-100.11%
CAICaris Life Sciences Inc - Class A27.98%-100.11%
JAZZJazz Pharmaceuticals plc27.42%-100.11%
SPROSpero Therapeutics Inc24.90%-100.10%
INCYIncyte Corp23.83%-100.10%
REGNRegeneron Pharmaceuticals Inc20.17%-100.08%
NAGENiagen Bioscience Inc20.07%-100.08%
ICCCImmucell Corp18.75%-100.08%
NERVMinerva Neurosciences Inc17.79%-100.07%
ALNYAlnylam Pharmaceuticals Inc16.99%-100.07%
ENVBEnveric Biosciences Inc16.64%-100.07%
TECHBio-Techne Corp16.39%-100.07%
HRMYHarmony Biosciences Holdings Inc15.08%-100.06%
ONCBeiGene Ltd15.02%-100.06%
RIGLRigel Pharmaceuticals14.71%-100.06%
BMRNBiomarin Pharmaceutical Inc13.77%-100.06%
VXRTVaxart Inc13.20%-100.05%
IMCRImmunocore Holdings plc12.16%-100.05%
VRNAVerona Pharma Plc11.56%-100.05%
TGTXTG Therapeutics Inc9.65%-100.04%
APLSApellis Pharmaceuticals Inc6.95%-100.03%
PTGXProtagonist Therapeutics Inc6.71%-100.03%
NUVBNuvation Bio Inc - Class A6.48%-100.03%
FBIOPFortress Biotech Inc6.40%-100.03%
GMABGenmab5.92%-100.02%
SRPTSarepta Therapeutics Inc2.98%-100.01%
BMEABiomea Fusion Inc2.37%-100.01%
ACADAcadia Pharmaceuticals Inc1.36%-100.01%
FENCFennec Pharmaceuticals Inc1.33%-100.01%
FOLDAmicus Therapeutics Inc0.91%-100.00%
HOTHHoth Therapeutics Inc0.17%-100.00%
BBLGBone Biologics Corp0.02%-100.00%